In navigating the multifaceted landscape of marijuana policy reform, the FDA’s exhaustive examination of cannabis, supplemented by insights from social media analysis, illuminates the intricate dynamics at play. Despite the agency’s recommendation for rescheduling, political pressures from congressional figures and stakeholders present hurdles towards a definitive decision.
New aggregated polls reveal that 55% of respondents believe marijuana is not dangerous, and a…
Every Croptober, growers waste time on folklore instead of physics. We break down the science…
Leafly's 2026 cannabis voter guide for the midterms is the only plan you need to…
Come along on an Emerald Triangle road trip with Lindsay MaHarry to see some of…
This month an Iowa church got what every sacramental-plant congregation dreams about: a path to…
The cannabis industry does not need another study, another tax revenue report, or another state-level…